The resulting FAS mRNA variant lacks exon 6 and translates into soluble Fas that retains its ability to bind the Fas ligand and blocks interaction with the Fas-receptor and pro-apoptotic signaling in human cancer cells [56]. This evidence concerns the gene FAS and cancer.